Neurology News
Expand your brainpower with neurology news focused on the diagnosis and treatment of nervous system disorders. Find the latest research in brain development and advancements in the treatment of tumors, seizure and spinal cord disorders, muscular dystrophy, multiple sclerosis, Alzheimer’s and infections of the nervous system, such as meningitis.
Nkrumah Neurosurgery & Spine Brings World-Class Care to Mineola with New Flagship Location
Nkrumah Neurosurgery & Spine is opening a new flagship location in Mineola, NY, bringing world-class spine and neurological care to the community. Led by Dr. Louis John Nkrumah, the Yale and Johns Hopkins–trained neurosurgeon, the facility will serve as the main hub for consultations and outreach, expanding access to advanced, patient-centered treatment across Long Island. - November 12, 2025 - Nkrumah Neurosurgery & Spine
Radial Celebrates the Grand Opening of Its Second South Carolina Clinic in Downtown Conway
More than 60 community members and business leaders join for ribbon cutting ceremony with the Conway Chamber of Commerce. - October 11, 2025 - Radial
Aquaterra Biotech Launches Integrated DNA-to-GMP CDMO Platform in Québec
Aquaterra Biotech Launches Integrated Microbial CDMO Platform from DNA Design to GMP Release Aquaterra Biotech announced an integrated contract development and manufacturing (CDMO) platform that advances microbial and recombinant programs from DNA design to GMP release and logistics. Headquartered... - September 30, 2025 - Aquaterra Biotech
The FOXG1 Research Foundation Announces FDA Award of Orphan Drug Designation for FRF-001 Gene Therapy, Following Rare Pediatric Disease Designation
The FOXG1 Research Foundation announced the FDA has granted Orphan Drug and Rare Pediatric Disease designations to FRF-001, its gene therapy for FOXG1 syndrome. FRF-001 marks a historic first: a parent-led foundation sponsoring its own international, multi-site clinical trial. - September 29, 2025 - FOXG1 Research Foundation
Alera Bio Launches Lead Rare Disease Program with Exclusive Rights to MCT-8 Deficiency Therapy
Alera Bio secures exclusive license to advance AB-101, a first-in-class program for MCT-8 deficiency, with FDA Rare Pediatric Disease designation already in place. - September 18, 2025 - Alera Bio
BioSensics Awarded $5.2M NIH Grant to Advance Digital Biomarkers for PSP and DLB
BioSensics has received a 5-year/$5.2 million grant from the National Institutes of Health (NIH) to develop and validate novel digital biomarkers of disease activity in progressive supranuclear palsy (PSP) and dementia with Lewy bodies (DLB). This 5-year project will leverage BioSensics’ expertise in wearable sensors and digital health technologies and involve close collaboration with leading CurePSP Centers of Care and patient advocacy groups. - September 17, 2025 - BioSensics LLC
Med-Care Providers Expands Telehealth, Mental Health, and In-Home Primary Care Services in Las Vegas
Med-Care Providers, a Nevada-based healthcare practice, announces the expansion of its services including telehealth, primary care, psychiatry, counseling, neurofeedback therapy, pain management, and in-home visits. The practice is committed to improving accessibility and outcomes for patients in Las Vegas and across Nevada. - August 28, 2025 - Med-Care Providers
BrainWorks Behavioral Health Expands Psychological and Neuropsychological Services to Los Angeles & Orange Counties with New Los Angeles, Whittier and Irvine Offices
BrainWorks Behavioral Health has expanded into Los Angeles and Orange Counties with new offices in Los Angeles, Whittier, and Irvine. The clinics provide autism testing, ADHD evaluations, therapy, and counseling for children, teens, and adults. For over a decade, BrainWorks has delivered compassionate care across Southern California, now bringing necessary psychological and neuropsychological services to more families. - August 27, 2025 - BrainWorks Behavioral Health
Eminent Spine Reports 70% Growth in Trailing 12-Month Income and Celebrates Alpha Launch of FDA-Approved 3D Printed Titanium Pedicle Screw
Eminent Spine announced today that its trailing twelve-month total income for the period ending June 2025 has risen by nearly 70%, underscoring the company’s strong momentum and expanding presence in the spine market. This milestone comes as the company celebrates the Alpha Launch of the... - August 18, 2025 - Eminent Spine
Dr. Fauzia Paracha Joins New York Cancer & Blood Specialists
New York Cancer and Blood Specialists (NYCBS) is proud to announce the addition of board-certified Hematologist-Oncologist Fauzia Paracha, MD. Dr. Paracha will see patients at 1200 Stony Brook Ct. Newburgh, NY 12550. With over 20 years of experience treating cancer patients, Dr. Paracha is... - August 07, 2025 - New York Cancer & Blood Specialists
HCA HealthONE Swedish is Nationally Recognized for Its Commitment to Providing High-Quality Stroke Care
HCA HealthONE Swedish earned the American Heart Association’s Gold Plus award for excellence in stroke care, along with multiple honors for rapid treatment and care for high-risk patients. As Colorado’s first Comprehensive Stroke Center, Swedish leads the region in advanced neurological care and outcomes. - July 27, 2025 - HCA HealthONE Swedish
ALS Network Selects TrialX to Power Its First AI-Based Clinical Trial Finder for the ALS Community
The ALS Network, a mission-driven organization committed to advancing treatments and improving quality of life for people living with amyotrophic lateral sclerosis (ALS), has launched its first AI-based clinical trial finder—powered by TrialX—to help individuals and families affected by ALS access personalized, up-to-date information about clinical trials. - July 18, 2025 - TrialX
ALS TDI Announces New Agreement with Axol Bioscience to Expand Access to ALS Patient iPSC-Derived Cells for Global Research
The ALS Therapy Development Institute (ALS TDI) is proud to announce that a collection of cells derived from ALS patient-derived induced pluripotent stem cell (iPSC) lines will now be made widely available to researchers around the world. - June 24, 2025 - ALS Therapy Development Institute
MindScape Retreat Releases Landmark Case Study Showing 70% Average Symptom Improvement in Parkinson’s Patients Following Ibogaine Treatment in Mexico
MindScape Retreat in Cozumel, Mexico has released a groundbreaking case study showing a 70% average improvement in Parkinson’s symptoms following a 14-day ibogaine therapy program. Among 30 patients, 52% symptom relief was seen by Day 4, with further gains by Day 14. A quarter of participants who continued microdosing post-retreat maintained or improved results. The therapy, using Ibogaine HCl and TA, showed strong safety and potential neuroregenerative benefits via GDNF activation. - May 02, 2025 - MindScape Retreat
Clubhouse International Hosts Global Initiative to Raise Critical Funds and Awareness for the Clubhouse Approach to Recovery
Clubhouse Giving Day™, a global initiative dedicated to supporting mental health recovery through the Clubhouse Model, will take place on May 1, rallying communities across the world to raise awareness and essential funding for Clubhouses — community-based centers that offer people... - May 01, 2025 - Clubhouse International
Huntington Study Group Announces Executive Director of Clinical Operations
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to introduce Carolyn Schultz-Walter as the Executive Director of Clinical Operations. With over 25 years of global clinical operations experience spanning both sponsor and clinical research... - March 31, 2025 - Huntington Study Group
ALS Therapy Development Institute Joins DataCite to Expand Access and Impact of ARC Dataset
The ALS Therapy Development Institute (ALS TDI) is pleased to announce its acceptance as a member of DataCite, a leading global organization dedicated to ensuring research is openly available and accessible across scientific disciplines. This partnership will significantly enhance the... - March 18, 2025 - ALS Therapy Development Institute
MemoryCareAI Transitions to Scienza Health, Advancing Early Detection with AI and Extensive Patient Data
New Name Reflects Expanded Focus on Cognitive and Behavioral Health Research - March 14, 2025 - Scienza Health
Augie’s Quest to Cure ALS Completes $5.8 Million Commitment to Fund ALS TDI’s Translational Research Center
The ALS Therapy Development Institute (ALS TDI) is proud to announce that Augie’s Quest to Cure ALS has fulfilled its $5.8 million commitment, pledged in 2021, to advance ALS research. This transformative funding has directly supported the Augie’s Quest Translational Research Center... - December 13, 2024 - ALS Therapy Development Institute
NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research
NeuroDex Awarded Target ALS Biomarker Consortia Grant to Drive Advancements in ALS Research - November 09, 2024 - NeuroDex
Synaps Dx Launches Digital Cognitive Screening and Alzheimer’s Testing with BrainCheck and Clarity Health Clinics
Synaps Dx, BrainCheck, and Clarity Health introduce an innovative online Alzheimer's and cognitive health screening tool, accessible from home. Launching in Texas, with nationwide expansion planned, this telehealth solution provides families with a convenient, reliable path to early detection during National Alzheimer’s Disease Awareness Month, reducing the need for in-office visits and empowering proactive cognitive care. - November 04, 2024 - SynapsDx
Rare Disease Foundation on the Road to Gene Therapy Brings Families to Fort Lauderdale from Around the World, November 15-17
The FOXG1 Research Foundation, the parent-led organization that is radically transforming the rare disease drug development landscape, is hosting an international conference in Fort Lauderdale from November 15-17, bringing families from across the globe together to learn about gene therapy advancements for FOXG1 syndrome. A highlight includes a presentation by 20-year-old Abraham Weitzman, who, though non-speaking, shares his lived experience using an innovative communication device. - November 04, 2024 - FOXG1 Research Foundation
Championing the Theme, Equity Works, Clubhouse International Partners with World Federation for Mental Health and 25 Clubhouses for World Mental Health Day
This World Mental Health Day, Clubhouse International is joined by 25 participating member Clubhouses and the World Federation for Mental Health for a campaign that champions the transformative power of equity, a critical aspect of the Clubhouse approach to recovery, which helps empower individuals and transform communities. - October 10, 2024 - Clubhouse International
October is Havana Syndrome Awareness Month
October is Havana Syndrome Awareness Month. The purpose is to raise awareness about Havana Syndrome injuries caused by directed energy. - October 05, 2024 - Havana Syndrome, Inc.
Adapy, Inc. Awarded Phase 1 SBIR Grant by NIDILRR to Advance Mobility Solutions
Adapy, Inc. has received a Phase 1 SBIR grant from NIDILRR to advance its innovative harness technology interfacing with its Smart Mobility System. This grant supports Adapy’s mission to improve mobility for individuals with disabilities, enhancing safety and independence. - October 02, 2024 - Adapy, Inc.
Dr. Pratistha Sachan, Renowned Vertigo Specialist, Delivers Pioneering Case Presentation at NESCON 2024
Dr. Pratistha Sachan, the foremost Vertigo Specialist and first Certified Vestibular Specialist in Lucknow, recently delivered a pioneering case presentation at NESCON 2024. Her presentation focused on the latest advancements in vertigo diagnosis and treatment, showcasing her innovative approaches to managing complex vestibular disorders. Dr. Sachan's participation in this prestigious event highlights her commitment to excellence in patient care. - September 08, 2024 - Dr Pratistha Sachan
Huntington Study Group and HD Genetics Collaborate to Better Serve HD Gene Positive Patients
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce a strategic partnership with HD Genetics to assist patients who have tested positive for Huntington’s disease (HD) learn about and enroll in research studies. There remains a... - September 05, 2024 - Huntington Study Group
ALS Therapy Development Institute Commemorates 25th Anniversary at the Leadership Weekend in October
Taking place from October 3-5, 2024, in the Boston area, ALS TDI’s Leadership Weekend features a series of community-focused events, including an Open House at ALS TDI’s cutting-edge research lab, the ALS TDI Research Summit, and the White Coat Affair gala. - September 03, 2024 - ALS Therapy Development Institute
Huntington Study Group Announces New CEO
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce that Daniel Claassen, MD, MS, an internationally recognized Huntington’s Disease neurologist and researcher has accepted the role as the organization’s Chief Executive... - August 20, 2024 - Huntington Study Group
Blink DC Launches Its Second Generation TwitchView® System, A Quantitative Neuromuscular Monitor
Blink Device Company announces the launch of the TwitchView®2 System, the second generation of its electromyographic (EMG) quantitative neuromuscular monitoring system. A complete redesign based on experience in over 1,000,000 clinical cases around the world. Designed to withstand OR abuse and to perform reliably in even the most difficult-to-monitor patients. - August 14, 2024 - Blink Device Company
Silver Scott Mines, Inc. Signs Letter of Intent to Acquire Innovative, Patented Non-Invasive Brain Treatment Technology
Silver Scott Mines will be acquiring the assets of AddBrain, Inc.’s technology. It has been used to treat Huntington’s Disease, Parkinson’s and Suicidal Depression with excellent results. There are ongoing clinical trials in Canada. - August 02, 2024 - Silver Scott Mines, Inc.
SYNAPS Dx Welcomes Renowned Alzheimer’s Researcher, Dr. Donna Wilcock, to Its Scientific Advisory Board
SYNAPS Dx welcomes Dr. Donna M. Wilcock, a leading Alzheimer's researcher, to its Scientific Advisory Board. Dr. Wilcock's expertise in neuroinflammation and vascular cognitive impairment will support the advancement of the DISCERN™ diagnostic test for Alzheimer's disease. This addition reinforces SYNAPS Dx’s commitment to pioneering accurate, minimally invasive diagnostics for Alzheimer's. For more info, visit SYNAPS Dx's website. - July 15, 2024 - SynapsDx
SYNAPS Dx Announces Expansion to New, State-of-the-Art Facility
SYNAPS Dx has moved to a new, state-of-the-art facility in Rockville, MD, to meet growing demand and enhance patient care. The larger space and advanced infrastructure will support more diagnostic samples and ensure timely, accurate Alzheimer's and dementia diagnoses. Fully qualified for high-complexity clinical lab testing, the facility boosts diagnostic capabilities. The expansion will also advance the DISCERN™ test, a minimally invasive tool distinguishing Alzheimer's from other dementias. - June 26, 2024 - SynapsDx
Groundbreaking Study Shows Promise in AAV9 Gene Therapy for FOXG1 Syndrome; Rescue of Brain Structure Abnormalities and Deficits.
New publication shows groundbreaking result in FOXG1 AAV9 gene therapy studies, rescuing structural brain abnormalities caused by the pediatric rare disease, FOXG1 syndrome. This paper summarizing work done by the FOXG1 Research Center, led by Dr. Soo-Kyung Lee, Dr. Jae W. Lee and Dr. Kathrin Meyer (responsible for the SMA gene therapy), shows remarkable rescue of brain abnormalities using AAV9 gene therapy. - June 10, 2024 - FOXG1 Research Foundation
JSE Releases New Streamline EHR to Increase Productivity
In an era where technology continually reshapes industries, Juggernaut Systems Express stands out as a beacon of innovation. With a solid foundation of twelve years in the market, the company has leveraged its extensive experience to develop MindTherapy.works, a cutting-edge application designed to... - June 03, 2024 - Juggernaut Systems Express
Vesalio Appoints CFO and Announces Company Headquarters in Dallas, Texas
Vesalio hires J.D. McCulloch as Chief Financial Officer and announces the establishment of the company’s headquarters in Dallas, Texas. - May 21, 2024 - Vesalio
Clubhouse International and Fountain House Launch 2024 Clubhouse Week of Action
Clubhouse International and Fountain House today announced their 2024 Clubhouse Week of Action, a dedicated time when Clubhouses across the country will be engaging their representatives, local businesses, the media, and others in the community on the holistic Clubhouse Model of mental illness recovery. - May 21, 2024 - Clubhouse International
Huntington Study Group Launches Project AWARE 2.0 Observational Study
The Huntington Study Group® and HSG Clinical Research, Inc. (together, “HSG”) are pleased to announce the launch of Project AWARE 2.0, an observational study developed in collaboration with Roche Products Limited and Genentech to understand and improve Awareness, Willingness, and... - April 10, 2024 - Huntington Study Group
Understanding Parkinson's Disease at Right at Home's Community Speaker Session
Right at Home is honored to announce the next free community speaker session, which aims to educate and empower the community about Parkinson's Disease. - April 01, 2024 - Right at Home - In-Home Care & Assistance
ALS TDI Launches ALS Trial Navigator: A Revolutionary Platform to Simplify Access to Clinical Trials
The ALS Therapy Development Insitute (ALS TDI) has announced the beta launch of the ALS Trial Navigator. This innovative set of tools is designed to guide people with ALS and caregivers through the process of finding and understanding ALS clinical trials – with the ultimate goal of personalizing the search process and helping users make informed decisions about participation in trials. - February 29, 2024 - ALS Therapy Development Institute
Black Hills Surgical Hospital Ranked #1 Hospital in the Nation for 2nd Consecutive Year for Major Orthopedic Surgery in Medical Excellence and Patient Safety Rankings
For the second year in a row, Black Hills Surgical Hospital (BHSH) has been ranked as the #1 Hospital in the Nation for Major Orthopedic Surgery for Medical Excellence by CareChex®. BHSH has also been ranked as the #1 Hospital in the Nation for Major Orthopedic Surgery for Patient Safety – achieving the nation’s top ranking in both categories. - February 19, 2024 - Black Hills Surgical Hospital
Huntington Study Group Announces 2024 Annual Meeting
The Huntington Study Group® (HSG), together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease (HD), is pleased to announce that its annual meeting for 2024 is slated to take place from November 6-9 at the... - January 22, 2024 - Huntington Study Group
TrialX Partners with The Michael J. Fox Foundation to Power Its Parkinson’s Clinical Trial Finder
To increase accessibility of information for individuals and families affected by Parkinson’s disease. - January 08, 2024 - TrialX
Clubhouse International Celebrates 30 Years of Change
Clubhouse International, the only global non-profit, non-governmental organization that helps communities around the world create sustainable solutions for mental illness, celebrates the 30th Anniversary of its founding in 2024. Joel D. Corcoran, CEO and Executive Director of Clubhouse... - January 04, 2024 - Clubhouse International
Dementia Society of America Named Finalist in Anthem Awards for Its National PSA Campaign
Dementia Society of America® (DSA) announced that it has been selected as a Finalist in the 3rd Annual Anthem Awards for its national Public Service Announcement (PSA) campaign. This campaign has been instrumental in driving awareness and education about Dementia and promoting brain health... - January 01, 2024 - Dementia Society of America
Christopher Ng, MD, Joins New York Health as Chief Medical Officer - Executive Director
New York Health (NY Health) is proud to announce the appointment of Christopher Ng, MD, as its new Chief Medical Officer (CMO) and Executive Director. As CMO, Dr. Ng will lead and oversee all medical aspects of the practice, ensuring the delivery of outstanding medical care while complying with... - December 19, 2023 - New York Health
Huntington Study Group and Roche Collaborate on GENERATION HD2 Study
The Huntington Study Group together with its wholly-owned clinical research organization, HSG Clinical Research, Inc. (HSGCR), is pleased to announce a collaboration with Roche-Genentech to optimize our collective experiences in Huntington’s disease (HD) clinical research. Together we are... - December 13, 2023 - Huntington Study Group
Expert Panel Provides Updated Data for Epilepsy and Pregnancy
The Epilepsy & Pregnancy Medical Consortium, an expert panel of leading epileptologists and OB-GYN researchers/practitioners, announced updated best practice recommendations for people with epilepsy who are considering pregnancy, are pregnant, or are postpartum. These new best practices are... - November 16, 2023 - Epilepsy & Pregnancy Medical Consortium
Indiana Parkinson Foundation Announces Pickleball 4 Parkinson’s Event
The Indiana Parkinson Foundation has officially announced its inaugural 2023 Pickleball 4 Parkinson’s Event. This single-day event will have beginner, advanced and intermediate rounds as well as courts reserved to teach players with Parkinson’s how they can adapt and play their best... - November 01, 2023 - Indiana Parkinson Foundation
Palliative Medicine Physician Joannis Baez Gonzalez, MD, Joins New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS), one of the nation's leading oncology practices, is proud to announce the addition of board-certified Palliative Medicine Physician Dr. Baez Gonzalez. Dr. Baez Gonzalez will practice at 6118 190th Street, Suite 217, Fresh Meadows, NY... - November 01, 2023 - New York Cancer & Blood Specialists